Abstract | OBJECTIVE: METHODS AND RESULTS: Oxidation of nLDL increases p38(MAPK) activation through a mechanism that is (1) independent of LPA, and (2) unlike nLDL-signaling not desensitized by prolonged platelet- LDL contact or inhibited by receptor-associated protein or chondroitinase ABC. Antibodies against scavenger receptors CD36 and SR-A alone fail to block p38(MAPK) activation by oxLDL but combined blockade inhibits p38(MAPK) by >40% and platelet adhesion to fibrinogen under flow by >60%. Mouse platelets deficient in either CD36 or SR-A show normal p38(MAPK) activation by oxLDL but combined deficiency of CD36 and SR-A disrupts oxLDL-induced activation of p38(MAPK) by >70%. CONCLUSION: These findings reveal a novel platelet-activating pathway stimulated by oxLDL that is initiated by the combined action of CD36 and SR-A.
|
Authors | Suzanne J A Korporaal, Miranda Van Eck, Jelle Adelmeijer, Martin Ijsseldijk, Ruud Out, Ton Lisman, Peter J Lenting, Theo J C Van Berkel, Jan-Willem N Akkerman |
Journal | Arteriosclerosis, thrombosis, and vascular biology
(Arterioscler Thromb Vasc Biol)
Vol. 27
Issue 11
Pg. 2476-83
(Nov 2007)
ISSN: 1524-4636 [Electronic] United States |
PMID | 17761940
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CD36 Antigens
- Lipoproteins, LDL
- Scavenger Receptors, Class A
- oxidized low density lipoprotein
- p38 Mitogen-Activated Protein Kinases
|
Topics |
- Animals
- Blood Platelets
- CD36 Antigens
(physiology)
- Humans
- Lipoproteins, LDL
(physiology)
- Mice
- Mice, Knockout
- Platelet Activation
(physiology)
- Scavenger Receptors, Class A
(physiology)
- Signal Transduction
(physiology)
- p38 Mitogen-Activated Protein Kinases
(metabolism)
|